Lisanti Capital Growth, LLC Procept Bio Robotics Corp Transaction History

Lisanti Capital Growth, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	BUY	$48.82 - $65.05 $2.15 Million - $2.86 Million	43,965 New	43,965 $2.53 Million
Q4 2024 Feb 06, 2025	SELL	$67.27 - $99.45 $1.36 Million - $2.02 Million	-20,280 Reduced 33.26%	40,685 $3.28 Million
Q3 2024 Nov 04, 2024	SELL	$56.31 - $84.99 $2.16 Million - $3.25 Million	-38,275 Reduced 38.57%	60,965 $4.88 Million
Q2 2024 Jul 31, 2024	SELL	$45.73 - $69.19 $64,707 - $97,903	-1,415 Reduced 1.41%	99,240 $6.06 Million
Q1 2024 May 06, 2024	SELL	$40.38 - $50.75 $849,393 - $1.07 Million	-21,035 Reduced 17.29%	100,655 $4.97 Million

Q4 2023 Feb 06, 2024	BUY	$24.89 - $43.41 $3.03 Million - $5.28 Million	121,690 New	121,690 $5.1 Million
Q2 2023 Aug 11, 2023	BUY	$26.7 - $37.02 $1.65 Million - $2.29 Million	61,730 New	61,730 $2.18 Million

272

49.1M

274K

376K

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $1.32B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.